文献速递乳房整形与再造

23301例乳房再造90天再手术比较:即刻与延迟、直接植入物或自体组织再造

Comparing 90-Day Reoperations in 23,301 Breast Reconstructions: Immediate Versus Delayed Direct-to-Implant or Autologous Reconstructions.
PubMed 文献 · Ann Plast Surg · 2025-06-11

该研究基于Kaiser Permanente 2010-2022年电子病历系统,纳入23272例乳腺癌乳房切除后再造病例(即刻18248例,延迟5025例),比较再造时机与90天再手术的关联。多变量调整后,即刻再造再手术比值比显著高于延迟再造(OR=1.96,95%CI 1.65-2.33,P<0.0001);即刻直接植入物再造再手术比值比最高(OR=5.55,95%CI 2.08-4.67,P=0.039);自体重建中即刻与延迟无显著差异。

要点

  • 即刻再造(含扩张器或直接植入物)90天再手术风险高于延迟再造。
  • 即刻直接植入物再造再手术比值比最高(OR=5.55)。
  • 自体重建中即刻与延迟再造再手术无显著差异。

核心结论

  • 即刻再造(扩张器或直接植入物)较延迟再造增加90天再手术风险。
  • 自体重建(单期或两期)中即刻与延迟再造再手术风险无显著差异。

研究设计与样本

  • 基于Kaiser Permanente 2010-2022年电子病历系统的队列研究。
  • 共纳入23272例乳腺癌乳房切除后再造病例(即刻18248例,延迟5025例)。
  • 以再造时机为暴露,按再造技术分层,采用单变量和多变量logistic回归分析90天再手术。

主要发现

  • 多变量调整后,即刻再造再手术比值比高于延迟再造(OR=1.96,95%CI 1.65-2.33,P<0.0001)。
  • 扩张器再造患者中,即刻再造再手术比值比升高(OR=1.83,95%CI 1.43-2.33,P<0.0001)。
  • 即刻直接植入物再造再手术比值比最高(OR=5.55,95%CI 2.08-4.67,P=0.039)。
  • 自体重建中即刻与延迟再造再手术无显著差异(单期或两期)。

临床怎么用

  • 选择即刻再造(尤其直接植入物)时需充分评估90天再手术风险。
  • 自体重建中即刻与延迟再造的再手术风险相近,可结合患者情况个体化决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In recent years, breast reconstruction following mastectomy has gained popularity. This study aimed to compare short-term unplanned return to the operating room (OR) for women undergoing breast reconstruction after mastectomy for malignancy by reconstruction timing, delayed compared to immediate (IBR). Subcategories of direct-to-implant and primarily autologous reconstruction were analyzed. METHODS: Data from an integrated electronic medical record system identified patients undergoing breast reconstruction after mastectomy at Kaiser Permanente facilities between 2010-2022. Reconstruction timing was the exposure of interest, with stratification based on reconstructive techniques including tissue expander followed by either implant or autologous reconstruction, direct-to-implant, or primarily autologous reconstruction. Univariable and multivariable logistic regression models assessed the association between reconstruction timing and 90-day reoperations in direct-to-implant or primarily autologous reconstruction, using delayed reconstruction as the reference. RESULTS: A total of 23,272 cases were identified (immediate = 18,248, delayed = 5025). The IBR patients exhibited higher odds of reoperations [odds ratio (OR) = 1.96, 95% confidence interval (CI) = 1.65-2.33, P < 0.0001] compared to delayed reconstruction after covariate adjustment. Among patients with expanders, IBR increased reoperation odds (OR = 1.83, 95% CI = 1.43-2.33, P < 0.0001). Immediate direct-to-implant reconstruction had the highest reoperation odds (OR = 5.55, 95% CI = 2.08-4.67, P = 0.039). No significant differences were observed between immediate and delayed approaches in autologous reconstruction, regardless of whether it was conducted in a single- or 2-stage process. CONCLUSIONS: Immediate reconstruction, involving expanders or direct-to-implant reconstructions, showed increased 90-day reoperation risks compared to delayed reconstruction. Conversely, no significant differences were identified between IBR and delayed reconstruction with autologous reconstruction conducted in a single- or 2-stage process.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Royse KE, Smith TM, Tan CM, et al. Comparing 90-Day Reoperations in 23,301 Breast Reconstructions: Immediate Versus Delayed Direct-to-Implant or Autologous Reconstructions. Ann Plast Surg. 2025. PMID: 40532244. doi:10.1097/SAP.0000000000004421

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。